EFFECT OF 1-(2'-DEOXY-2'-FLUORO-BETA-D-ARABINOFURANOSYL)-5-ETHYLURIDINE (FEAU) ON HERPES KERATITIS IN RABBITS

被引：0

|

作者：

TROUSDALE, MD

SU, TL

WATANABE, KA

FOX, JJ

机构：

[1] DOHENY EYE INST,LOS ANGELES,CA

[2] SLOAN KETTERING INST CANC RES,NEW YORK,NY 10021

来源：

ANTIVIRAL RESEARCH | 1988年 / 9卷 / 1-2期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：144 / 144

页数：1

相关论文

共 50 条

[1] HUMAN CYTOMEGALOVIRUS-INDUCED DNA-POLYMERASE AND ITS INTERACTION WITH THE TRIPHOSPHATES OF 1-(2'-DEOXY-2'-FLUORO-BETA-D-ARABINOFURANOSYL)-5-METHYLURACIL, 1-(2'-DEOXY-2'-FLUORO-BETA-D-ARABINOFURANOSYL)-5-IODOCYTOSINE, AND 1-(2'-DEOXY-2'-FLUORO-BETA-D-ARABINOFURANOSYL)-5-METHYLCYTOSINE
MAR, EC
CHIOU, JF
CHENG, YC
HUANG, ES
JOURNAL OF VIROLOGY, 1985, 56 (03) : 846 - 851
[2] SYNTHESIS AND ANTIVIRAL ACTIVITY OF PHOSPHOLIPID DERIVATIVES OF 1-(2'-DEOXY-2'-FLUORO-BETA-D-ARABINOFURANOSYL)-5-IODOURACIL (FIAU) AND 1-(2'-DEOXY-2'-FLUORO-BETA-D-ARABINOFURANOSYL)-5-IODOCYTIDINE (FIAC)
STUHMILLER, LM
HOSTETLER, KY
KING, DH
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1990, 200 : 133 - MEDI
[3] EVALUATION OF 1-(2'-DEOXY-2'-FLUORO-BETA-D-ARABINOFURANOSYL)-5-ETHYLURACIL IN A RABBIT MODEL OF HERPETIC-KERATITIS
TROUSDALE, MD
LAW, JL
YARBER, FA
WATANABE, KA
FOX, JJ
ANTIVIRAL RESEARCH, 1992, 17 (02) : 157 - 167
[4] Imaging [18F]FAU [1-(2′-deoxy-2′-fluoro-beta-D-arabinofuranosyl)uracil] in dogs
Sun, HH
Collins, JM
Mangner, TJ
Muzik, O
Shields, AF
NUCLEAR MEDICINE AND BIOLOGY, 2003, 30 (01) : 25 - 30
[5] A PROPOSED MECHANISM FOR THE SELECTIVE-INHIBITION OF HUMAN CYTOMEGALOVIRUS REPLICATION BY 1-(2'-DEOXY-2'-FLUORO-BETA-D-ARABINOFURANOSYL)-5-FLUOROURACIL
SUZUKI, S
MISRA, HK
WIEBE, LI
KNAUS, EE
TYRRELL, DLJ
MOLECULAR PHARMACOLOGY, 1987, 31 (03) : 301 - 306
[6] SELECTIVE-INHIBITION OF DNA-REPLICATION IN HERPES-SIMPLEX VIRUS-INFECTED CELLS BY 1-(2'-DEOXY-2'-FLUORO-BETA-D-ARABINOFURANOSYL)-5-IODOCYTOSINE
ALLAUDEEN, HS
DESCAMPS, J
SEHGAL, RK
FOX, JJ
JOURNAL OF BIOLOGICAL CHEMISTRY, 1982, 257 (20) : 1879 - 1882
[7] DISTRIBUTION, METABOLISM, AND EXCRETION OF 1-(2-FLUORO-2-DEOXY-BETA-D-ARABINOFURANOSYL)THYMINE AND 1-(2-FLUORO-2-DEOXY-BETA-D-ARABINOFURANOSYL)-5-IODOCYTOSINE
PHILIPS, FS
FEINBERG, A
CHOU, TC
VIDAL, PM
SU, TL
WATANABE, KA
FOX, JJ
CANCER RESEARCH, 1983, 43 (08) : 3619 - 3627
[8] ACTIVITY OF 1-(2'-DEOXY-2'-FLUORO-BETA-D-ARABINOFURANOSYL)-5-IODOURACIL AGAINST SIMIAN VARICELLA VIRUS-INFECTIONS IN AFRICAN-GREEN MONKEYS
SOIKE, KF
CANTRELL, C
GERONE, PJ
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (01) : 20 - 25
[9] PHASE-I TRIAL OF 1-(2'-DEOXY-2'-FLUORO-1-BETA-D-ARABINOFURANOSYL)-5-METHYLURACIL (FMAU)
FANUCCHI, MP
LEYLANDJONES, B
YOUNG, CW
BURCHENAL, JH
WATANABE, KA
FOX, JJ
CANCER TREATMENT REPORTS, 1985, 69 (01): : 55 - 59
[10] DERIVATIVES OF 1-(2-DEOXY-2-FLUORO-BETA-D-ARABINOFURANOSYL)-5-PHENYLURACIL AND 1-(2-DEOXY-2-FLUORO-BETA-D-ARABINOFURANOSYL)-5-BENZYLURACIL - SYNTHESIS AND SOME BIOLOGICAL PROPERTIES
DZIEWISZEK, K
SU, TL
WATANABE, KA
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1990, 200 : 136 - MEDI

← 1 2 3 4 5 →